Acutus Medical Inc.
(AFIB)
undefined
undefined%
At close: undefined
0.06
-1.64%
After-hours May 08, 2024, 07:59 PM EDT
Company Description
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally.
The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.
Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Acutus Medical Inc.
| Country | United States |
| IPO Date | Aug 6, 2020 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 230 |
| CEO | Takeo Mukai |
Contact Details
Address: 2210 Faraday Avenue Carlsbad, California United States | |
| Website | https://www.acutusmedical.com |
Stock Details
| Ticker Symbol | AFIB |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001522860 |
| CUSIP Number | 005111109 |
| ISIN Number | US0051111096 |
| Employer ID | 45-1306615 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Takeo Mukai | Chief Executive Officer & Chief Financial Officer |
| Gary W. Doherty B.S. | Senior Vice President of Finance |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 04, 2024 | 8-K | Current Report |
| Nov 15, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | 8-K | Current Report |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 17, 2024 | 8-K | Current Report |
| Aug 08, 2024 | 10-Q | Quarterly Report |
| Aug 08, 2024 | 8-K | Current Report |
| Jun 14, 2024 | 8-K | Current Report |
| May 17, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |